Lp(a) apheresis and CVD risk modulation - PACE-CME

Lpa apheresis and CVD risk modulation

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
The Imminent danger of Lp(a): Time to face to challenge
Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
- Prof. Børge Nordestgaard, MD
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
The Imminent danger of Lp(a): Time to face to challenge
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
- Prof. Sam Tsimikas
LDL vs Lp(a) cholesterol: confounding
LDL vs Lp(a) cholesterol: confounding
The Imminent danger of Lp(a): Time to face to challenge
LDL vs Lp(a) cholesterol: confounding
- Calvin Yeang, MD, PhD
Are we ready for prime-time Lp(a) assay standardization?
Are we ready for prime-time Lp(a) assay standardization?
The Imminent danger of Lp(a): Time to face to challenge
Are we ready for prime-time Lp(a) assay standardization?
- Prof. Santica Marcovina